Abstract: This invention describes the novel use of alkyl, alkoxyl, halogenyl, or hydroxy substituted dicinnamoylquinides as therapeutic agents for enhancing adenosine levels in the brain and peripheral organs. These agents are particularly useful in treating human diseases or conditions that benefit from acute or chronic elevated levels of adenosine, such as reperfusion injury, coronary or cerebral ischemia, coronary vasoconstriction, paroxysmal supraventricular tachycardia, hypertension, wound healing, diabetes, inflammation, or sleep disturbances. They can also be used to protect normal cells from chemotoxicity in patients undergoing cancer therapy, and reverse the behavioral effects of caffeine intake.

Abstract: A foaming device including a housing with a cylindrical passage therethrough and four housing ports which provide communication between exterior and interior of the housing, the housing ports being connected to sources of fluids; a cylindrical spool slidably disposed within the housing provided with an axial passage therethrough and three spool ports in communication with the spool passage; the spool being displaceable to on, off and cleaning positions in a way that one has to go through the cleaning position when displacing the spool from the on to off position or vice versa.